EVO ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) and astigmatism. Unlike some other vision correction options, the EVO ICL is an additive technology that corrects vision without the removal of any corneal tissue. The EVO ICL is meant to reduce or eliminate the need for glasses or contacts and unlike most permanent refractive solutions, EVO ICL is removable.
EVO ICL is made of biocompatible Collamer material that works in harmony with your eye. Your eye doctor will create a small opening in your cornea that will be used to insert and position the EVO ICL. The procedure is typically painless with numbing eye drops and it typically takes less than 20 minutes. You can experience improved vision right away and a quick recovery time.
• Significant vision improvement1
• 99% patient satisfaction2
• Over 1 million procedures performed worldwide3
• Quick results
• Can be removed if needed
• Offers UV protection
• Can treat astigmatism and myopia
• Undetectable once in place
• May be an option for patients who are not candidates for other vision correction procedures4
• Does not cause dry eye syndrome, which can be a side effect of other vision correction procedures5
• Provides excellent night vision6
1 Shin, JY. Ahn, H. Seo, KY. Kim, EK. Kim, TK. Comparison of higher order aberrations after implantable collamer lens implantation and wavefront-guide LASEK in high myopia. J Refract Surg. 2012; 28 (2): 106 -111
2 MICL PMA data
3 Data on file. STAAR Surgical.
4 Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473 – 481
5 Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
6 Parkhurst G. A Prospective Comparison of Phakic Collamer Lenses and Wavefront-Optimized Laser-Assisted in Situ Keratomileusis for Correction of Myopia. Clinical Ophthalmology 2013; 10: 1209-1215.
Dr Joseph Ling is a fellowship-trained refractive surgeon specialized in the full-spectrum of vision correction. He is the refractive lens and laser specialist at the Laser Eye Center of Silicon Valley. He is widely published in scientific and clinical journals for his work in ophthalmology and molecular biology. He was also involved in clinical trials, including insertable collamer lens (ICL), intraocular lenses (IOLs), and refractive lasers.
Many EVO ICL patients look forward to spending less in the long run with the Visian ICL compared to the continued costs of contacts and glasses. We will review all of your financing options and payment plans that may be available for your Visian ICL procedure at the time of your free exam to determine if you are a candidate.
“I had my first opportunity to put my EVO ICL eyes to the test recently in the Brazilian Rainforest, and it couldn’t have been more exciting to be able to spot rare species better than ever.”
PHIL TORRES, ENTOMOLOGIST, TV SHOW HOST
“I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market.”
SARA TSO, CHEF
EVO ICL is well-suited for a wide variety of people. Ideal candidates for EVO ICL are aged 21 to 45 nearsightedness and have maintained a stable prescription for at least one year. EVO ICL is not an option for patients who are pregnant, nursing, or those with a history of eye disease. If you are seeking a solution to decrease or eliminate the cost or frustration of traditional contacts or glasses, EVO ICL may be your answer. Schedule your FREE Eye Exan and Consultation today to see if EVO ICL is right for you.
It is once again Sunday afternoon as I write this post about another exciting technology in vision correction. EVO Visian ICL is an Implantable Collamer Lens used to correct near-sightedness. While our practice has been performing the ICL procedure for many years, I am thrilled that this newest version – EVO – is now available for our patients in our San Jose location.
What is EVO Visian ICL? EVO ICL is a refractive surgery that can correct myopia (near-sightedness) with or without astigmatism. It is made of Collamer, a biocompatible material that is flexible and works in harmony with your eye. EVO ICL is an additive technology without the removal of any corneal tissue, and unlike most permanent refractive solutions, it can be removed.
What is the difference between EVO Visian ICL and other procedures such as LASIK? EVO ICL is an intraocular procedure that is an additive; no significant change to the eye itself. On the other hand, LASIK, SMILE, or PRK are corneal procedures that reshape the cornea. Visual outcome and recovery between the types of procedures are very similar. The key difference is that EVO ICL does not alter the cornea, which allows certain individuals with thin corneas to receive vision correction.
What is it like to get EVO Visian ICL done? We perform EVO ICL in-office. The procedure is comfortable throughout the entire process and typically painless. The only sensation would be the numbing eye drops, a bright light and occasional pressure. The procedure typically takes 20-30 minutes. Vision can be noticeably clearer immediately and there would be no sensation of the implant being there.
Who is a good candidate for EVO Visian ICL? EVO ICL is an excellent procedure for anyone between the ages of 21 and 45 seeking treatment for near-sightedness, with or without astigmatism. It is a game changer for those who were denied vision correction due to their high prescriptions or thin corneas. The procedure is safe for those with active lifestyles, and stable in their current prescription for at least one year.
I hope this has been informative. I enjoy giving patients the ability to see without glasses and contacts. The best way to learn more is to come visit us, and see if you are a candidate for EVO Visian ICL. I look forward to seeing you soon.
Joseph Ling, MD
References:
